VISYNC

What this means for you

Not registered yet, but its 12 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79423184

Mark type

Stylized text

Filed

12 Dec 2024

Attorney of record

R. Peter Spies

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations all of the foregoing for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; biopharmaceutical preparations for the treatment of inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders and advanced therapy medicinal products (atmps), namely, Gene Therapy Medicinal Products (GTMPs), Somatic Cell Therapy Medicinal Products (sCTMPs), Tissue Engineered Products (TEPs), and Combined ATMPs; medicines for human use that are based on genes, tissues or cells for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; drugs for medical purposes, namely, pharmaceutical preparations for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; pharmaceutical preparations for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; biopharmaceutical preparations for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management and advanced therapy medicinal products (atmps) for systemic or targeted delivery, namely, nasal spray preparations suitable for nasal delivery, nose-to-brain delivery for medical purposes; advanced therapy medicinal products (atmps), namely, Gene Therapy Medicinal Products (GTMPs), Somatic Cell Therapy Medicinal Products (sCTMPs), Tissue Engineered Products (TEPs), and Combined ATMPs, medical and veterinary preparations, namely, medical and veterinary preparations comprising biomolecules, cells, viruses, virus-like particles, exosomes, nanoparticles or liposomes for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; vaccines; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents and kits consisting primarily of probes, buffers and reagents for use in microbial testing.
• Class 010 — Medical apparatus: Surgical, medical and veterinary apparatus and instruments for medical, dental or veterinary use; medical apparatus and instruments, namely, drug delivery devices, sold empty, in the nature of syringes, infusion sets, inhalers and diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, cancer cells, DNA; diagnostic, examination and monitoring equipment in the nature of imaging equipment, microscopes, blood analysers (haematology analysers), biochemistry analysers, immunoassay analysers, microbiology incubators, centrifuges.
• Class 042 — Scientific and technological services: Scientific and technological consulting services in the pharmaceutical industry and research and design relating thereto; industrial analysis in the nature of product testing, industrial research and industrial design services in the field of pharmaceutical, veterinary and medical goods; quality control of services for others and providing user authentication services using single sign-on technology for online software applications; pharmaceutical and biological analysis and research services; medical research relating to the research, development and manufacturing activities in the field of medicines, namely biomolecules, cells, viruses, virus-like particles, exosomes, nanoparticles, liposomes and vaccines; medical research relating to the research, development and manufacturing activities in the field of delivery of medicines namely, nasal spray preparations suitable for nasal delivery, nose-to-brain delivery; technological research being research and development of manufacturing processes for the pharmaceutical industry; optimization of processes in the nature of technological consultancy services for search engine optimization for the pharmaceutical industry; design and development of medical diagnostic apparatus for detecting inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; scientific research for medical purposes in the area of inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders.
• Class 044 — Medical, beauty and agricultural services: Medical diagnostic services; handling of blood samples in the nature of blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; performing diagnosis of diseases

Owner

• VISYNC TECHNOLOGIES, S.A., PT

Prosecution history

• 21 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 21 Feb 2026 — FINAL REFUSAL E-MAILED
• 21 Feb 2026 — FINAL REFUSAL WRITTEN
• 28 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 28 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 28 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 16 Aug 2025 — REFUSAL PROCESSED BY IB
• 28 Jul 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 28 Jul 2025 — REFUSAL PROCESSED BY MPU
• 05 Jun 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 04 Jun 2025 — NON-FINAL ACTION WRITTEN
• 30 May 2025 — ASSIGNED TO EXAMINER
• 09 May 2025 — APPLICATION FILING RECEIPT MAILED
• 09 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 08 May 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB